340 related articles for article (PubMed ID: 33705876)
1. Dry powder pharmaceutical biologics for inhalation therapy.
Chang RYK; Chow MYT; Khanal D; Chen D; Chan HK
Adv Drug Deliv Rev; 2021 May; 172():64-79. PubMed ID: 33705876
[TBL] [Abstract][Full Text] [Related]
2. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics.
Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Vehring R
Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804
[TBL] [Abstract][Full Text] [Related]
3. Dosing considerations for inhaled biologics.
Ferrati S; Wu T; Kanapuram SR; Smyth HDC
Int J Pharm; 2018 Oct; 549(1-2):58-66. PubMed ID: 30053488
[TBL] [Abstract][Full Text] [Related]
4. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
[TBL] [Abstract][Full Text] [Related]
5. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P
Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426
[TBL] [Abstract][Full Text] [Related]
6. Amorphous powders for inhalation drug delivery.
Chen L; Okuda T; Lu XY; Chan HK
Adv Drug Deliv Rev; 2016 May; 100():102-15. PubMed ID: 26780404
[TBL] [Abstract][Full Text] [Related]
7. Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.
Farinha S; Sá JV; Lino PR; Galésio M; Pires J; Rodrigues MÂ; Henriques J
Pharm Res; 2023 May; 40(5):1115-1140. PubMed ID: 36456666
[TBL] [Abstract][Full Text] [Related]
8. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
9. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.
Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR
Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064
[TBL] [Abstract][Full Text] [Related]
10. Development of inhalable dry powder formulation of basic fibroblast growth factor.
Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
[TBL] [Abstract][Full Text] [Related]
11. Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach.
Ferrati S; Wu T; Fuentes O; Brunaugh AD; Kanapuram SR; Smyth HDC
AAPS PharmSciTech; 2018 Oct; 19(7):2755-2766. PubMed ID: 29488193
[TBL] [Abstract][Full Text] [Related]
12. Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.
Wilson EM; Luft JC; DeSimone JM
Pharm Res; 2018 Aug; 35(10):195. PubMed ID: 30141117
[TBL] [Abstract][Full Text] [Related]
13. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
14. Leucine as an excipient in spray dried powder for inhalation.
Alhajj N; O'Reilly NJ; Cathcart H
Drug Discov Today; 2021 Oct; 26(10):2384-2396. PubMed ID: 33872799
[TBL] [Abstract][Full Text] [Related]
15. Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
Miller DP; Tan T; Tarara TE; Nakamura J; Malcolmson RJ; Weers JG
Mol Pharm; 2015 Aug; 12(8):2582-93. PubMed ID: 26052676
[TBL] [Abstract][Full Text] [Related]
16. Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.
Eedara BB; Alabsi W; Encinas-Basurto D; Polt R; Mansour HM
AAPS PharmSciTech; 2021 Jun; 22(5):185. PubMed ID: 34143327
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
[TBL] [Abstract][Full Text] [Related]
18. Effect of storage temperature on the stability of spray dried bacteriophage powders.
Leung SSY; Parumasivam T; Nguyen A; Gengenbach T; Carter EA; Carrigy NB; Wang H; Vehring R; Finlay WH; Morales S; Britton WJ; Kutter E; Chan HK
Eur J Pharm Biopharm; 2018 Jun; 127():213-222. PubMed ID: 29486303
[TBL] [Abstract][Full Text] [Related]
19. Protein Aggregates in Inhaled Biologics: Challenges and Considerations.
Ibrahim M; Wallace I; Ghazvini S; Manetz S; Cordoba-Rodriguez R; Patel SM
J Pharm Sci; 2023 May; 112(5):1341-1344. PubMed ID: 36796636
[TBL] [Abstract][Full Text] [Related]
20. Efficient optimization of high-dose formulation of novel lyophilizates for dry powder inhalation by the combination of response surface methodology and time-of-flight measurement.
Ohori R; Kiuchi S; Sugiyama S; Miyamoto K; Akita T; Yamashita C
Int J Pharm; 2020 May; 581():119255. PubMed ID: 32217154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]